SBIR Funding Opportunities

FOA# Topic/Title Budget Deadline
RFA-MH-21-112 Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R43/R44 Clinical Trial Optional) $256,580 February 18, 2021
RFA-GM-21-001 Regional Technology Transfer Accelerator Hubs for IDeA States (STTR) (UT2 – Clinical Trial Not Allowed) $1.7 M per year January 5, 2021
NOT-AT-21-001 Notice of Special Interest (NOSI): Development and/or Validation of Devices or Electronic Systems to Monitor or Enhance Mind and Body Interventions (SBIR/STTR) Standard SBIR January 5, 2021 – January 5, 2024
PAR-21-030 Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed) $300 K Ph. I, $2 M Ph. II January 5, 2021
NOT-HD-20-025 Notice of Special Interest: Innovative Technologies to Improve Assessments, Interventions, and Outcomes for Individuals with Intellectual and Developmental Disabilities (R43/R44) standard SBIR/STTR budgets January 5 2021 – January 8, 2022
RFA-ES-20-016 NIEHS SBIR Phase IIB Validation of Sensors for Improved Environmental Exposure Assessment (R44 Clinical Trial Not Allowed) $1 M per year December 4, 2020
75N91020R00043 National Cancer Institute (NCI) Small Business Innovation Research (SBIR) Phase 0 Concept Award Program – Fiscal Year 2021
PAR-20-128 SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, Clinical Trial Not Allowed) $250 – $300K Standard SBIR dates
PAR-20-129 SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed) varies by IC Standard SBIR dates
PAR-20-130 SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required) varies by IC Standard SBIR dates
PA-20-260 PHS 2020 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) $256,580 for Phase I, $1,710,531 for Phase II Standard SBIR dates
PA-20-261 PHS 2020-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required) $256,580 for Phase I, $1,710,531 for Phase II Standard SBIR dates
PA-20-262 PHS 2020-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) $256,580 for Phase I, $1,710,531 for Phase II Standard SBIR dates
PA-20-265 PHS 2020-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) $256,580 for Phase I, $1,710,531 for Phase II Standard SBIR dates
NOT-MH-20-013 Notice of Special Interest (NOSI): Mental Health Comorbidities in HIV Prevention and Treatment
NOT-MH-20-020 Notice of Special Interest: Stigma or Other Social Determinants of Health (SDOH) in HIV Prevention and Treatment
NOT-MH-20-023 Notice of Special Interest (NOSI): Strengthening the HIV Care Continuum
NOT-MH-20-024 Notice of Special Interest (NOSI): Implementation Science to Advance the United States HIV Prevention and Treatment Goals and the Global HIV Prevention and Treatment Targets
NOT-MH-20-035 Notice of Special Interest: Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults
PAR-18-801 Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R44 – Clinical Trial Optional) $300 K Phase I, $2 M Ph II Standard Dates
NOT-AI-20-031 Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) April 5, 2020-April 5, 2021
PAR-20-109 Non-Viral Technologies for in vivo Delivery of Genome Editors (R41/R42 Clinical Trial Not Allowed) Standard Phase I, II budgets Standard SBIR/STTR dates
PAR-20-098 Non-Viral Technologies for in vivo Delivery of Genome Editors (R43/R44 Clinical Trial Not Allowed) Standard Phase I, II budgets Standard SBIR/STTR dates
PA-20-025 Development of Highly Innovative Tools and Technology for Analysis of Single Cells (STTR) (R41/R42 Clinical Trial Not Allowed) Standard NIH STTR Budgets April 6, 2020 until Jan 6, 2023
PA-20-047 Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44 Clinical Trial Not Allowed) Standard NIH STTR Budgets April 6, 2020 until Jan 6, 2023
FOA# Topic/Title Budget Deadline
NSF 20-546 Dear Colleague Letter: Request for SBIR/STTR Phase I Proposals Addressing COVID-19 $256 ASAP
NSF 20-545 SBIR Phase II $1 M Feb 14-Dec. 3, 2020
NSF 20-546 STTR Phase II $1 M Feb 14-Dec. 3, 2020
FOA# TOPIC/TITLE BUDGET DEADLINE
DOE Phase I Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Funding Opportunities $200 – 250 K Letter of Intent due January 4, 2020
DE-FOA-0002380 DEPARTMENT OF ENERGY (DOE) FY 2021 PHASE II RELEASE 1 $1.1 M or $1.6 M LOI December 8, 2020
FOA# Topic/Title Budget Deadline
HR001120S0019-25 STTR Opportunity: Thermal Emission Control using Dynamic Structured Materials $250 K January 5, 2021
HR001120S0019-26 SBIR Opportunity: Smart Hemorrhage Control and Resuscitation at Point of Injury $250 K January 5, 2021
HR001120S0019-27 SBIR Opportunity: Rapid and automated sterility testing of biologics $500 K January 5, 2021
HR001120S0019-23 Regional Technology Transfer Accelerator Hubs for IDeA States (STTR) (UT2 – Clinical Trial Not Allowed) Ph. I $317,808, Direct to Phase II $2.25 M December 17, 2020
HR001120S0019-24 STTR Opportunity: High-throughput, non-destructive methods for elemental analysis of environmental microbes $225 K December 17, 2020
DOD SBIR 2020.6 Army SBIR 2020.6 (Direct to Phase II) $1.67 M December 15, 2020
DoD DARPA SBIR/STTR $250 K December 31, 2020
FOA# TOPIC/TITLE BUDGET DEADLINE
70RSAT-SBIR-FY21 SMALL BUSINESS INNOVATION RESEARCH (SBIR) PROGRAM FY 21 $100 K January 15, 2021
FOA# TOPIC/TITLE BUDGET DEADLINE
Sensor Technology for the 21st Century varies varies